Joint Formulary & PAD

Naltrexone - Alcohol dependence

You are here : Home > Formulary Search > Naltrexone - Alcohol dependence

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Red
Formulations :
  • Tablets
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
R
SPC
Restrictions / Comments :
Important

To prevent relapse in former alcohol-dependant patients.

Restricted to Drugs & Alcohol Service only.

Documentation

Information
Abstinence drugs - APC Briefing paper - Sept 2021

PAD Profile

ChemicalSubstance :
Naltrexone
Indication :
Alcohol dependence
Group Name :
Keywords :
alcohol abstinence, abstinence from alcohol, alcohol dependency, alcohol abuse
Brand Names Include :
Adepend
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
1

Committee Recommendations (1)

01 Sep 21 - Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

The Surrey Heartlands integrated care system Area Prescribing Committee (APC) agreed the use of naltrexone and acamprosate for reducing alcohol consumption in people with alcohol dependence.

Naltrexone and acamprosate will be given a RED traffic light status, for prescribing by Drug and Alcohol teams only.

Any prescribing established in primary care prior to this decision may continue.

Other Indications

Below are listed other indications that Naltrexone is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Alcohol dependence.